The estimated Net Worth of Christopher Gerard is at least $11.9 Million dollars as of 2 August 2021. Mr. Gerard owns over 1,250 units of Amedisys stock worth over $3,661,432 and over the last 8 years he sold AMED stock worth over $4,108,058. In addition, he makes $4,161,280 as Chief Operating Officer at Amedisys.
Christopher has made over 27 trades of the Amedisys stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 1,250 units of AMED stock worth $326,550 on 2 August 2021.
The largest trade he's ever made was exercising 17,496 units of Amedisys stock on 12 February 2020 worth over $1,692,213. On average, Christopher trades about 2,207 units every 38 days since 2017. As of 2 August 2021 he still owns at least 37,856 units of Amedisys stock.
You can see the complete history of Mr. Gerard stock trades at the bottom of the page.
Christopher T. Gerard serves as Chief Operating Officer of the Company since January 2017. He previously served as President for the South Central Region of Kindred at Home, a division of Kindred Healthcare, Inc., a healthcare services company, from 2015 to 2016. Prior to his role as Regional President, Mr. Gerard was the Chief Operating Officer at Kindred at Home from 2014 to 2015. Mr. Gerard joined Kindred in 2012 as Regional Vice President when Kindred acquired IntegraCare Holdings, Inc., a home health, hospice and community care agency based in Grapevine, Texas. Mr. Gerard was an original founder of IntegraCare in 1998 and served as its President and Chief Executive Officer from 2007 to 2012.
As the Chief Operating Officer of Amedisys, the total compensation of Christopher Gerard at Amedisys is $4,161,280. There are 1 executives at Amedisys getting paid more, with Paul Kusserow having the highest compensation of $12,835,500.
Christopher Gerard is 53, he's been the Chief Operating Officer of Amedisys since 2017. There are 15 older and 4 younger executives at Amedisys. The oldest executive at Amedisys Inc. is Molly Coye, 72, who is the Independent Director.
Christopher's mailing address filed with the SEC is 3854 AMERICAN WAY, SUITE A, , BATON ROUGE, LA, 70816.
Over the last 27 years, insiders at Amedisys have traded over $269,564,877 worth of Amedisys stock and bought 2,690,968 units worth $38,198,016 . The most active insiders traders include Asset Management Llc Kohlbe..., Tide Capital, Llc North Tid..., and David Nierenberg. On average, Amedisys executives and independent directors trade stock every 29 days with the average trade being worth of $2,494,602. The most recent stock trade was executed by Richard M Ashworth on 26 December 2023, trading 11,237 units of AMED stock currently worth $896,937.
amedisys is a leading provider of healthcare in the home with a vision of becoming the premiere solution for patients across the country to age in place. from home health to hospice to personal care, amedisys team members provide quality, clinically-distinctive care to more than 376,000 patients every year. every life is precious and tells an incredible story, and we celebrate that each day by honoring our patients with genuine, personal attention. everything we do, from the boardroom to our nationwide network of care centers, is centered on the best care possible for those who have entrusted us with their well-being and comfort. we work closely with doctors and other healthcare providers to coordinate services, and every patient has an individual plan of care that meets their specific needs. amedisys recognizes that nothing we do is possible without our incredible team. for all employees, whether they’re on the front lines delivering direct care or supporting our clinical team, this i
Amedisys executives and other stock owners filed with the SEC include: